Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00130377
Recruitment Status : Unknown
Verified January 2018 by Amit N. Patel MD MS, Amit, Patel N, M.D..
Recruitment status was:  Recruiting
First Posted : August 15, 2005
Last Update Posted : January 19, 2018
Information provided by (Responsible Party):
Amit N. Patel MD MS, Amit, Patel N, M.D.

Brief Summary:
This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- University of Utah in order to obtain access to the registry. The are predetermined case report forms for cardiovascular diseases that are currently in clinical trials- including demographics, safety, and possible efficacy end-points. All investigators have access to their own data. The servers are U.S. HIPPA compliant and protected with secure back-up.

Condition or disease Intervention/treatment Phase
Cardiovascular System Diseases (& [Cardiac]) Biological: cell therapy Phase 2 Phase 3

Detailed Description:

The clinical cell registry includes data on thoracic and cardiovascular diseases including:

Acute myocardial infarction, Chronic Angina, Heart Failure, Wound Healing including Sternal, Peripheral Arterial Disease, Critical Limb Ischemia, Type 2 Diabetes, COPD, Asthma. Neurological disorders registry is available to specifics sites if requested. Our own biological data at the University of Utah including co-localized data with Society of Thoracic Surgeons also is a part of this program. Cell based therapies that are autologous and allogeneic are included in the registry

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1000 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Biological Cell Therapy for the Treatment of Patients With Thoracic & Cardiovascular Disease
Study Start Date : August 2002
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Arm Intervention/treatment
Experimental: cell therapy
Patient receiving active biologic
Biological: cell therapy
autologous or allogeneic cells

Placebo Comparator: control
Patient receiving placebo or standard of care
Biological: cell therapy
autologous or allogeneic cells

Primary Outcome Measures :
  1. Safety - MACE - Death, Readmission, Reintervention [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age >=18 years old
  • Approved consent to be enrolled in trial/registry

Exclusion Criteria:

  • Prior malignancy in the 5 years before treatment in this study (other than curatively treated carcinoma in-situ of the cervix or non-melanoma skin cancer)
  • Inability or unwillingness to comply with the treatment protocol, follow-up, research tests, or give consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00130377

Layout table for location contacts
Contact: Amit N. Patel, MD, MS
Contact: Amit N Patel, MD,MS

Layout table for location information
United States, Utah
University of Utah Recruiting
Salt Lake City, Utah, United States, 84132
Contact: Amit Patel, MD MS   
Contact: Kristin Kolsch   
Principal Investigator: Amit Patel, MDMS         
Sponsors and Collaborators
Amit N. Patel MD MS
Layout table for investigator information
Principal Investigator: Amit N. Patel, MD, MS University of Utah
Publications of Results:
Other Publications:
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Amit N. Patel MD MS, Amit Patel, Amit, Patel N, M.D. Identifier: NCT00130377    
Other Study ID Numbers: 0506137
First Posted: August 15, 2005    Key Record Dates
Last Update Posted: January 19, 2018
Last Verified: January 2018
Keywords provided by Amit N. Patel MD MS, Amit, Patel N, M.D.:
Stem Cell
cell therapy registry
Additional relevant MeSH terms:
Layout table for MeSH terms
Cardiovascular Diseases